Stockreport
A Look At Gilead Sciences (GILD) Valuation After Recent Mixed Share Price Performance [Yahoo! Finance]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Recent performance snapshot for Gilead Sciences (GILD) Without a specific news event driving the latest move, Gilead Sciences (GILD) currently trades at $140.30, with recent returns that differ over the past day, week, month, and past 3 months. See our latest analysis for Gilead Sciences. Recent trading has been mixed, with a 14.3% 3 month share price return but a 6.5% 1 month share price pullback. However, the 1 year total shareholder return of 28.7% points to momentum that is still intact. If you are weighing Gilead against other opportunities in healthcare, this is a useful moment to scan the market and see which peers are catching attention through 33 healthcare AI stocks With Gilead trading at $140.30, an intrinsic value estimate suggesting a 50.4% discount, and a value score of 4, the key question is whether this signals a genuine opportunity or if markets already reflect future growth. Most Popular Narrative: 10.9% Undervalued Against the last close at $140.30, t
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Gilead Extends Tender Offer to Acquire Arcellx[Business Wire]
- Gilead Sciences: Caution After A Re-Rating Amidst New Concentration Risks [Seeking Alpha][Seeking Alpha]
- Is Gilead (GILD) a Buy as Wall Street Analysts Look Optimistic? [Yahoo! Finance][Yahoo! Finance]
- Gilead: Why The 'Immune System Company' Pivot Is No Longer A Bargain (Downgrade) [Seeking Alpha][Seeking Alpha]
- Gilead to Acquire Ouro Medicines in $2.18B Deal, Expand Inflammation Pipeline [Yahoo! Finance][Yahoo! Finance]
- More
GILD
SEC Filings
SEC Filings
- 3/30/26 - Form 4
- 3/27/26 - Form 144
- 3/26/26 - Form SCHEDULE
- GILD's page on the SEC website
- More